Astonea Labs Stock Screener | Share Price & Fundamental Analysis
ASTONEALAB
Pharmaceuticals
Screen Astonea Labs share price with our stock screener - analyze fundamentals and track trades in your journal
Market Cap
₹171.88 Cr.
P/B Ratio
2.92
EPS (TTM)
₹6.94
Dividend Yield
-
Debt to Equity
3.16
52W High
-
52W Low
-
Operating Margin
-
Profit Margin
-
EBITDA
-
Net Income
-
Total Assets
₹103.00
Total Equity
₹18.00
Astonea Labs Share Price History - Stock Screener Chart
Screen ASTONEALAB historical share price movements with interactive charts. Analyze price trends and patterns.
Astonea Labs Company Profile - Fundamental Screener
Screen Astonea Labs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ASTONEALAB shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0TG901011
Astonea Labs Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen ASTONEALAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 103 | 81 | 64 | 53 |
| Current Assets | 71 | 55 | 43 | 31 |
| Fixed Assets | 25 | 22 | 21 | 21 |
| Liabilities | ||||
| Total Liabilities | 103 | 81 | 64 | 53 |
| Current Liabilities | 22 | 21 | 20 | 23 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||
| Total Equity | 18 | 12 | 8 | 8 |
| Share Capital | 8 | 8 | 4 | 4 |
| Reserves & Surplus | 11 | 4 | 4 | 4 |
Screen ASTONEALAB income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|---|
| Revenue | 0 | 98 | 80 | 67 | 30 |
| Expenses | 0 | 82 | 68 | 60 | 24 |
| EBITDA | 0 | 15 | 12 | 7 | 6 |
| Operating Profit % | 0.00% | 16.00% | 15.00% | 11.00% | 19.00% |
| Depreciation | 0 | 5 | 4 | 4 | 4 |
| Interest | 0 | 4 | 3 | 2 | 2 |
| Profit Before Tax | 0 | 7 | 5 | 1 | 1 |
| Tax | 0 | 2 | 1 | 0 | 0 |
| Net Profit | 0 | 5 | 4 | 1 | 0 |
| EPS | 0.00 | 6.94 | 5.36 | 0.88 | 0.33 |
Astonea Labs Cash Flow Screener - Liquidity Fundamentals
Screen ASTONEALAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
| Operating Activities | 9 | 8 | -1 | -5 |
| Investing Activities | -11 | -8 | -3 | -3 |
| Financing Activities | 2 | 0 | 4 | 8 |
| Net Cash Flow | 0 | -1 | 0 | 0 |
Screen ASTONEALAB shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-May | 2025-Jun | 2025-Sept | 2024-Aug |
|---|---|---|---|---|
| Promoter Holding | 72.30% | 72.30% | 72.30% | 98.43% |
| FII Holding | 0.00% | 8.01% | 2.51% | 0.00% |
| DII Holding | 0.00% | 4.55% | 0.35% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 12.24% | 11.51% | 17.06% | 0.00% |
| Other Holding | 15.45% | 3.62% | 7.77% | 1.57% |
| Shareholder Count | 36 | 1,014 | 437 | 36 |
Astonea Labs Dividend Screener - Share Yield Analysis
Screen ASTONEALAB dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Astonea Labs Index Membership - Market Screener Classification
Screen ASTONEALAB by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Astonea Labs Market Events Screener - Corporate Actions
Screen ASTONEALAB market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-12-27 | 2025-12-27 | Annual General Meeting | NA | 6.70% |
| 2025-11-10 | 2025-11-10 | Quarterly Result Announcement | NA | 2.50% |
| 2025-07-11 | 2025-07-11 | Quarterly Result Announcement | NA | 3.94% |
Astonea Labs Competitors Screener - Peer Comparison
Screen ASTONEALAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 412,614 | 39.35 | 54,729 | 9.71% | 10,980 | 38.94 |
| Divis Laboratories | 169,701 | 68.64 | 9,712 | 18.67% | 2,191 | 47.61 |
| Torrent Pharmaceuticals | 130,301 | 60.42 | 11,539 | 6.99% | 1,911 | 63.27 |
| Cipla | 122,079 | 22.17 | 28,410 | 7.12% | 5,291 | 50.85 |
| Dr Reddys Laboratories | 106,115 | 18.42 | 33,741 | 16.73% | 5,725 | 53.02 |
| Lupin | 96,362 | 21.87 | 22,910 | 13.74% | 3,306 | 57.47 |
| Zydus Life Science | 92,005 | 18.03 | 23,511 | 18.55% | 4,615 | 43.59 |
| Mankind Pharma | 90,673 | 50.11 | 12,744 | 20.90% | 2,007 | 49.10 |
| Aurobindo Pharma | 68,709 | 20.16 | 32,346 | 9.43% | 3,484 | 45.26 |
| Alkem Laboratories | 65,838 | 26.89 | 13,458 | 3.70% | 2,216 | 41.76 |
Astonea Labs Company Announcements - News Screener
Screen ASTONEALAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-03 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2026-01-02 | Reg. 34 (1) Annual Report. | View |
| 2026-01-02 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2026-01-02 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-12-16 | Corrigendum To Notice Of 8Th Annual General Meeting | View |
| 2025-12-04 | Reg. 34 (1) Annual Report. | View |
| 2025-12-03 | Reg. 34 (1) Annual Report. | View |
| 2025-12-03 | Of 8Th Annual General Meetings Of The Company To Be Held On 27Th December 2025. | View |
| 2025-12-03 | Appointment of Company Secretary and Compliance Officer | View |
| 2025-12-03 | Board Meeting Outcome for Held On 03Rd December 2025 | View |
| 2025-11-28 | Board Meeting Intimation for Board Meeting Intimation For Approval Of Notice Of AGM For The Financial Year 2024-25 And Consideration Of Various Matters | View |
| 2025-11-12 | Non Applicability Of Statement Of Deviation Or Variation Under Reg. 32(1) Of SEBI (Listing Obligations Disclosure Requirements) Regulations 2015 For The Quarter/Half Year Ended 30Th September 2025 | View |
| 2025-11-12 | Submission Of Half-Yearly Disclosure On Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended | View |
| 2025-11-11 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-11-10 | Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting Dated 10.11.2025 | View |
| 2025-11-06 | Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of The Un-Audited Financial Results For The Quarter/Half Year Ended 30Th September 2025 And Other Agendas. | View |
| 2025-10-15 | Statement Of Investors Complaints For Quarter Ended 30.09.2025 | View |
| 2025-10-14 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-20 | Board Meeting Outcome for Outcome Of Board Meeting Dated 20.09.2025 | View |
| 2025-09-20 | Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer | View |